PGHS2 has attracted the attention of the pharmaceutical companies for the development of selective inhibitors, which could be used both as anti-inflammatory compounds, as well to inhibit the proliferation of different types of cancer cells [17,23,24]. The gene discussed is PTGS2; the disease is cancer.